Novartis chairman quits as CEO

Daniel Vasella is stepping down from his role as chief executive of European pharmaceuticals company Novartis to concentrate on the chairmanship. He will be succeeded by Joe Jim enez, the American head of the group’s core pharmaceuticals division. The high profile executive has defended his role as both chief and chairman, but Swiss corporate governance lobbies welcomed the division of the two positions.